William Blair Has Weak Forecast for Amedisys FY2024 Earnings

Amedisys, Inc. (NASDAQ:AMED - Free Report) - Investment analysts at William Blair decreased their FY2024 earnings per share (EPS) estimates for Amedisys in a report released on Thursday, November 7th. William Blair analyst M. Larew now anticipates that the health services provider will post earnings per share of $4.40 for the year, down from their prior forecast of $4.72. The consensus estimate for Amedisys' current full-year earnings is $4.65 per share. William Blair also issued estimates for Amedisys' Q4 2024 earnings at $1.05 EPS and Q3 2025 earnings at $1.10 EPS.

A number of other brokerages have also weighed in on AMED. Cantor Fitzgerald restated a "neutral" rating and issued a $101.00 price objective on shares of Amedisys in a report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft cut Amedisys from a "buy" rating to a "hold" rating and set a $101.00 price objective on the stock. in a research note on Monday, July 29th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Amedisys currently has a consensus rating of "Hold" and an average target price of $100.67.

Amedisys Price Performance

AMED stock traded down $0.11 during mid-day trading on Monday, hitting $96.60. 324,553 shares of the stock were exchanged, compared to its average volume of 339,013. The business has a fifty day moving average price of $96.70 and a 200 day moving average price of $95.89. Amedisys has a 12 month low of $89.55 and a 12 month high of $98.95. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The stock has a market capitalization of $3.16 billion, a price-to-earnings ratio of 38.38, a PEG ratio of 1.92 and a beta of 0.78.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.34%. The company had revenue of $587.67 million during the quarter, compared to analysts' expectations of $586.75 million. During the same period in the prior year, the business earned $0.98 earnings per share. The company's revenue for the quarter was up 5.7% compared to the same quarter last year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of AMED. Arizona State Retirement System increased its position in Amedisys by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider's stock valued at $840,000 after purchasing an additional 177 shares during the period. Signaturefd LLC lifted its holdings in Amedisys by 20.9% in the third quarter. Signaturefd LLC now owns 1,367 shares of the health services provider's stock worth $132,000 after buying an additional 236 shares during the period. Price T Rowe Associates Inc. MD boosted its position in Amedisys by 0.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 31,199 shares of the health services provider's stock valued at $2,876,000 after acquiring an additional 255 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in shares of Amedisys by 7.2% during the 3rd quarter. State of Alaska Department of Revenue now owns 3,782 shares of the health services provider's stock worth $365,000 after acquiring an additional 255 shares during the period. Finally, CWM LLC lifted its stake in shares of Amedisys by 14.5% in the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider's stock valued at $211,000 after purchasing an additional 277 shares during the period. Institutional investors own 94.36% of the company's stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.